Physician

Adam Edward Singer

According to 2025 Medicare claims, Adam Singer (NPI: 1770014326) practices hematology/oncology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (NPI: 1235107566; TIN: 954373071) and primary practice location at 90505-6660.

Singer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 511 traditional Medicare patients, billed 59,429 HCPCS/CPT codes, and received $1,242,698 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 490 prescription claims across 96 beneficiaries totaling $2,389,918 in drug costs, led by Cabometyx (Cabozantinib S-Malate). 2023 DME data shows 39 claims. Open Payments data shows 9 records totaling $3,101. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $5,381 to $2,389,918. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.